Scholarly Index
Tian Zhang
Wenzhou Medical University; 12,864 total citations; 514 total publications; best world rank #33
Wenzhou Medical University
12,864Total citations
514Total publications
47H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Cancer Immunotherapy and Biomarkers | Lifetime | 884 | CN 54 | 98.18 |
| Renal cell carcinoma treatment | Lifetime | 566 | CN 6 | 97.69 |
| Economic and Financial Impacts of Cancer | Lifetime | 672 | CN 10 | 93.70 |
| Renal cell carcinoma treatment | 2021-2025 | 33 | CN 1 | 99.29 |
| Cancer Immunotherapy and Biomarkers | 2021-2025 | 149 | CN 22 | 99.44 |
| Cancer Genomics and Diagnostics | 2021-2025 | 200 | CN 11 | 98.43 |
| Renal and related cancers | 2021-2025 | 77 | CN 3 | 97.34 |
| Prostate Cancer Treatment and Research | 2021-2025 | 258 | CN 9 | 97.41 |
| Bladder and Urothelial Cancer Treatments | 2021-2025 | 237 | CN 16 | 97.05 |
| Esophageal Cancer Research and Treatment | 2021-2025 | 461 | CN 124 | 92.57 |
| Economic and Financial Impacts of Cancer | 2021-2025 | 300 | CN 17 | 92.01 |
| Urinary and Genital Oncology Studies | 2021-2025 | 644 | CN 38 | 85.86 |
| Brain Metastases and Treatment | 2021-2025 | 915 | CN 46 | 82.24 |
| PARP inhibition in cancer therapy | 2021-2025 | 844 | CN 86 | 79.97 |
| Multiple and Secondary Primary Cancers | 2021-2025 | 746 | CN 100 | 71.03 |